Lars Ottestad
Impact in
- Oncology top 2%
- Bone health and treatments
- Cancer-related Molecular Pathways
- Cancer Diagnosis and Treatment
- Cancer Risks and Factors
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 24
- HER2/EGFR in Cancer Research 8
- Cancer-related Molecular Pathways 6
- Bone health and treatments 5
- Cancer Cells and Metastasis 4
-
- Breast Cancer Treatment Studies 7
- Cancer Genomics and Diagnostics 5
- Co-authors
- Jürgen Geisler (7 shared papers)Per Eystein Lønning (8 shared papers)Eugène McCloskey (3 shared papers)Ian Smith (3 shared papers)Alwynne Tidy (3 shared papers)John А. Kanis (3 shared papers)S. Ashley (3 shared papers)Mitch Dowsett (2 shared papers)
- Journals
- British Journal of Cancer (6 papers)Journal of Clinical Oncology (5 papers)Genes Chromosomes and Cancer (3 papers)Acta Oncologica (2 papers)Radiotherapy and Oncology (1 paper)
- Partner nations
- NorwayUnited StatesUnited Kingdom
In The Last Decade
Lars Ottestad
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 83
- Oncology 1.2k
- Cancer Research 517
- Genetics 583
- Orthopedics and Sports Medicine 144
- Radiology, Nuclear Medicine and Imaging 371
Countries citing papers authored by Lars Ottestad
This map shows the geographic impact of Lars Ottestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ottestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ottestad more than expected).
Fields of papers citing papers by Lars Ottestad
This network shows the impact of papers produced by Lars Ottestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ottestad. The network helps show where Lars Ottestad may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Ottestad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 288 | |
| 2 | 2002 | 288 | |
| 3 | 2006 | 195 | |
| 4 | 1993 | 143 | |
| 5 | Screening for germ line TP53 mutations in breast cancer patients. | 1992 | 143 |
| 6 | Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer. | 2001 | 100 |
| 7 | 1992 | 93 | |
| 8 | 1990 | 89 | |
| 9 | 1990 | 58 | |
| 10 | 1997 | 58 | |
| 11 | Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer | 2006 | 48 |
| 12 | 2004 | 23 | |
| 13 | 2006 | 17 | |
| 14 | 2016 | 16 | |
| 15 | C-erbB-2 protein and neuroendocrine expression in breast carcinomas. | 1991 | 15 |
| 16 | 2004 | 14 | |
| 17 | 1991 | 13 | |
| 18 | 2012 | 12 | |
| 19 | 1993 | 11 | |
| 20 | 1993 | 11 |
About Lars Ottestad
Lars Ottestad is a scholar working on Oncology, Cancer Research, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 35 papers that have together received 1.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Estrogen and related hormone effects (8 papers), Breast Cancer Treatment Studies (7 papers), Cancer-related Molecular Pathways (6 papers), Cancer Genomics and Diagnostics (5 papers), Bone health and treatments (5 papers), Cancer Cells and Metastasis (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (517 citations), Genetics (583 citations), Orthopedics and Sports Medicine (144 citations) and Radiology, Nuclear Medicine and Imaging (371 citations). Lars Ottestad has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Jürgen Geisler, Per Eystein Lønning, Eugène McCloskey, Ian Smith, Alwynne Tidy, John А. Kanis, S. Ashley, Mitch Dowsett, Steinar Lundgren and P. Walton. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Genes Chromosomes and Cancer, Acta Oncologica and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.